Award
Delivery Order #SPE2D226F3002
Delivery Order Awarded to DMS Pharmaceutical Group for Lidocaine Hydrochloride Injection
Buyer
Defense Logistics Agency
Award Amount
$140.58
Ceiling
$140.58
Awarded
July 13, 2026
Period of Performance
Jul 13, 2026 – Jul 13, 2026
Identifier
SPE2D226F3002
NAICS
325411
This award is a delivery order contract executed under an existing indefinite delivery contract vehicle with DMS Pharmaceutical Group Inc., a prominent pharmaceutical manufacturer and distributor. The delivery order procures lidocaine hydrochloride injection, a critical medication used in various medical treatments. It supports government healthcare systems by ensuring the timely and reliable supply of essential drugs, thereby enhancing public health outcomes. The scope of work entails the delivery of the medication to a specified location in Park Ridge, Illinois, within a one-day performance window in mid-2026. This delivery order is a component of a substantial ongoing contract obtained through competitive bidding, reflecting a long-term commitment to maintaining steady access to vital pharmaceutical products. The parent indefinite delivery contract encompasses a wide range of essential drug products, contributing significantly to the government's healthcare supply chain.
Description
8512235373!LIDOCAINE HYDROCHLORIDE INJEC